Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading Companies - Gilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More

About this update from Gilead Sciences, Inc.

Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic production while reducing costs, fueling market growth and adoption Stem Cell and Regenerative Therapy Market Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Stem Cell and Regenerative Therapy: Global Markets" has been added to ResearchAndMarkets.com's offering. The global stem cell and regenerative therapy market is poised for substantial growth, with projections indicating an increase from $16.7 billion in 2025 to $43.8 billion by 2030, reflecting a compound annual growth rate (CAGR) of 21.3%. This burgeoning sector is driven by its potential to address chronic and challenging health conditions, including cancer, Parkinson's, Alzheimer's, diabetes, and cardiovascular diseases. Investments from private companies and governments worldwide are catalyzing progress in stem cell research, aiming to meet increasing demands for innovative treatment and prevention solutions for chronic diseases. Technological advancements are focusing on optimizing stem cell culture technology, contributing to reduced treatment costs and facilitating research advancements. Notable progress has been made in refining stem cell culture media formulations, culture systems, and the equipment used for stem cell development and processing. Report Scope The report offers a comprehensive analysis of the global stem cell and regenerative therapy market, covering market trends, revenue forecasts, and segmentation by products, services, application, and geographical regions, including North America, Europe, Asia-Pacific, and the Rest of the World. It delves into significant trends and challenges impacting the market and vendor landscape, with insights into environmental, social, and corporate governance (ESG) developments, emerging technologies, and the patent landscape. Concluding with an examination of the competitive landscape, the report provides ranking and shares of major companies within the global stem cell and regenerative medicine market. It features company profiles offering overviews, financial details, product portfolios, and recent developments of key market players. The report includes: Key Attributes Companies Featured For more information about this report visit https://www.researchandmarkets.com/r/jc4ijq About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

View stock analysis, news, and events for Gilead Sciences, Inc.